Louis Matis Net Worth & Insider Trades
Louis Matis - Chief Development Officer, Pieris Pharmaceuticals, Inc
What is Louis Matis's Net Worth?
The current estimated net worth of Pieris Pharmaceuticals, Inc's Chief Development Officer, Louis Matis, is estimated to be about $14.9K . Louis Matis owns about 10,000 units of Pieris Pharmaceuticals, Inc common stock. In the last 4 years at Pieris Pharmaceuticals, Inc, Louis Matis has sold an estimated value of $0 worth.
What is Louis Matis's Past Insider Trading?
Louis Matis's largest purchase order was 10,000 units , worth over $17.04K on June 15, 2016. In total, Louis Matis has made about 5 transactions over 4 years of their time at Pieris Pharmaceuticals, Inc. Louis Matis usually trades in February, with the busiest year in 2018, 2019, 2015, 2017 and 2016.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Louis Matis
Date Range: All Time
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||
InsideArbitrage
What is Louis Matis's' Mailing Address?
- Mailing address is Lise-Meitner-Strasse 30 C/o Pieris Pharmaceuticals, Inc. Freising-Weihenstephan 2M 85354 Germany
Pieris Pharmaceuticals, Inc Executive Compensation
Name |
Year
|
Salary
|
Option Awards
|
Other Earnings Plans or Compensations
|
Other Compensation
|
Total
|
|---|---|---|---|---|---|---|
| Stephen S. Yoder | 2020 | $535,000 | $808,699 | $173,875 | $21,255 | $1,538,829 |
| Stephen S. Yoder | 2019 | $515,000 | $815,670 | $208,575 | $54,353 | $1,593,598 |
| Hitto Kaufmann, Ph.D.* | 2020 | $330,583 | $86,646 | $107,143 | $20,958 | $545,330 |
| Hitto Kaufmann, Ph.D.* | 2019 | $108,176 | $956,299 | $36,804 | - | $1,101,279 |
| Thomas Bures | 2020 | $283,250 | $154,038 | $65,856 | $11,400 | $514,544 |
| Thomas Bures | 2019 | $257,500 | $152,938 | $66,242 | - | $476,680 |
| No matching records found | ||||||
Source: https://www.sec.gov/Archives/edgar/data/1583648/000158364821000015/pirs2021proxystatement.htm
What are Pieris Pharmaceuticals, Inc's Past Insider Trades?
Pieris Pharmaceuticals, Inc's most recent insider trade came on May 30, 2023 by Christopher Kiritsy who bought 10,000 units worth $8.5K . In the last 8 years, insiders at Pieris Pharmaceuticals, Inc have sold an estimated value of $25.85M and bought an estimated value of $3.66M worth of shares. Insider trading is most common in January and June, with the busiest year in 2017. The most active traders at the company are Michael Richman, Director, Christopher Kiritsy, Director, and Quang Chau Khuong .
PIERIS PHARMACEUTICALS, INC. Insider Trades
Date Range: All Time
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||